Objectives: To identify and describe protein expression in a Wistar rat calvarial critical size defect (CSD) model following treatment with guided bone regeneration in healthy and osteoporotic conditions.
differentiation of osteoblast cell precursors.
Osteoporosis is the most common chronic metabolic disease of the bone, which may interfere with bone regeneration processes (Jakob et al. 2013) . In order to successfully perform bone reconstructive treatments in osteoporotic patients, it is important to understand how this disease can affect the complex cascade of events taking place during osseous regeneration. Some of the key events taking place during bone formation have already been described (Perren 2014) ; however, most of the key signaling pathways and the relevant regulatory molecules involved still remain undetected. A greater understanding of these mechanisms may identify fundamental pathways that can be directly correlated with the clinical performance, in cases where bone defects have to be treated in osteoporotic patients.
Guided bone regeneration (GBR) is a therapeutic modality that was developed with the aim to stimulate bone regeneration by applying a barrier membrane (Dahlin et al. 1988) . The isolation of a bone defect with a barrier membrane prevents the down growth of epithelial cells and allows the repopulation of the defect by osteoprogenitor cells coming from the host bone. GBR potential has been extensively confirmed in critical size defects (CSD; Donos et al. 2004 Donos et al. , 2011a , which are defined as "the smallest size intra-osseous wounds in a particular bone and species that will not heal spontaneously during the lifetime of the animal" (Schmitz & Hollinger 1986) . GBR has also been applied for socket preservation, de novo bone formation (neoosteogenesis), and ridge augmentation concomitant or prior to implant placement, in healthy and medically compromised conditions (Donos et al. 2008 (Donos et al. , 2015 Retzepi & Donos 2010) .
Different bone grafts have been tested in combination with barrier membranes to reduce the risk of membrane collapse, to act as a scaffold for bone ingrowth (osteoconductive properties) and to protect the augmented volume from resorption (Donos et al. 2002a (Donos et al. , 2002b (Donos et al. , 2005b Retzepi & Donos 2010) .
Proteomics is the study of the full set of proteins (proteome) of a biological system and can be seen as an additional and more advanced step, after genomics and transcriptomics, for the study of a biological process. In fact, while the genome of an organism is the same in all cells, its phenotype and the subset of proteins produced can significantly change throughout time and depending on the different conditions. We hypothesized that protein expression and in vivo histological findings, if combined with a relevant experimental model for bone regeneration, might elucidate such specific biologic mechanisms implicated in osteoporotic osseous regeneration. This would potentially allow identifying also crucial target proteins/pathways for future research.
The aim of this study was to qualitatively describe the proteins expressed in a calvarial CSD model following GBR with a collagen membrane and deproteinized bovine bone mineral (DBBM) graft, in healthy and osteoporotic-like conditions.
Material and methods

Experimental surgical procedure
The protocol was described in detail elsewhere (Part 1). In summary, 18 ovariectomized (OVX) and 18 healthy control 10-month-old female Wistar rats were used. Six weeks after OVX, two 5-mm CSDs were created, one in the center of each parietal bone (Fig. 1a ) and they were treated according to the GBR principle. In particular, a resorbable collagen membrane (Geistlich Bio-Gide â , Geistlich, Wolhusen, Switzerland) was firstly adapted to the intracranial side of each defect, a deproteinized bovine bone mineral (DBBM) particulate graft (Geistlich Bio-Oss â , Geistlich, Wolhusen, Switzerland) was loosely placed into the defect and eventually covered by a second wider extracranial resorbable collagen membrane (Geistlich Bio-Gide â , Geistlich, Wolhusen, Switzerland; Fig. 1b and c) . Six OVX and six healthy control rats were randomly euthanized at 7, 14, and 30 days. During the sacrifice, one defect per animal was randomly chosen for proteomic analysis. The tissue within the defect was carefully collected with an excavator, placed into a sterile test tube, and stored at À80°C until analysis. Whenever possible and if not completely dissolved, the upper membrane covering the defect was removed before collecting the tissue for proteomic analysis.
During the sacrifice, one tibia per animal was also harvested, to histologically confirm that induced osteoporosis had occurred.
Two-dimensional gel electrophoresis (2-DE) and matrix-assisted laser desorption time-of-flight mass spectrometry (MALDI-TOF/MS)
Samples were homogenized with 250 ll of buffer (SB) and 9 ll of protease inhibitor (PI), they underwent multiple rounds of pestle homogenization, sonication (power at 40% for cell disruption), and centrifugation to separate the supernatant from pellets.
2-DE was firstly employed to separate the proteins, which were then identified according to their peptide mass fingerprint (PMF) with MALDI-TOF/MS, as previously described (Tsangaris et al. 2006; Anagnostopoulos et al. 2010) . Briefly, 1 mg of proteins from each sample was loaded onto 18-cm non-linear pI 3-10 and (when the amount of sample allowed) linear pI 4-7 Immobilized Ph Gradient (IPG) strips (Bio-Rad Lab, Hercules, CA, USA). Isoelectric focusing was performed for a total of approximately 93000Vh per strip.
The proteins resolved in IPG strips were then applied to homogeneous 12% sodium dodecyl sulfate polyacrylamide gels (SDS-PAGE) and separated according to their molecular weight in a Protein-II apparatus (Bio-Rad Lab). After a fixation step with a solution containing 30% methanol, 10% acetic acid, and 60% water, the gels were stained with colloidal Coomassie Blue and then scanned with PDQuest 8.0 software (Bio-Rad). Firstly the differently expressed proteins (spots) and then the remaining ones were semi-automatically annotated with Melanie 5 (Bio-Rad) software and excised with a ProteinerSpII robotic picker (Bruker Daltonics, Bremen, Germany). The spots were placed into 96-well microtiter plates and in-gel digested overnight with 3 ll of recombinant trypsin (Roche Diagnostics, Basel, Switzerland). Peptides were extracted by adding 10 ll of extraction solution (50% ACN, 0.1% trifluoroacetic acid) to each spot. The dry-droplet technique was eventually employed to apply the tryptic-digested peptides to a target plate for MALDI-TOF/MS, as previously described (Mavrou et al. 2008; Anagnostopoulos et al. 2010) . Smoothing was performed with the Savitzky-Golay algorithm (width 0.2 m/z, cycle number 1), S/N was calculated by SNAP algorithm, and a threshold ratio of 2.5 was allowed. Peptide matching and protein searches were automatically performed with MASCOT Server 2 (Matrix Science, London, UK) and using the Rodents Swiss-Prot database. A maximum allowed error of 10 ppm and a minimum of 4 ppm matching peptides were adopted. A peak list was obtained with FlexAnalysis v2.2 software (Brucker Daltonics, Billerica, MA, USA). A probability score of P < 0.05 was applied for protein identification.
Liquid chromatography-mass spectrometry/ mass spectrometry (LC-MS/MS)
For the 14-and 30-day samples, LC-MS/MS analysis was also performed and protein identification was obtained using a bottom-up approach. Considering the limited amount of proteins retrieved and that some samples were used to optimize the protocol (data not shown), we decided to pool together samples of the same group and healing period (pooling approach).
Excess blood removal from samples was carried out by three times washing in sucrose buffer, consisting of 20 mM HEPES, pH 7.5, 320 mM sucrose, 1 mM EDTA, 5 mM DTE, and 1 mg/ml of a mixture of protease inhibitors [1 mM PMSF and 1 tablet (Roche Diagnostics) per 50 ml of washing buffer and phosphatase inhibitors (0.2 mM Na 3 VO 3 and 1 mM NaF)]. All samples were initially Particularly, digested samples were analyzed using a Thermo Scientific linear iontrap (LTQ) mass spectrometer coupled with a Dionex 3000 HPLC system (Thermo Scientific, Rockford, IL, USA). Peptide separation took place on two Thermo Scientific columns (PepMap â RSLC, C18, 100 A, 3-lmbead-packed 15-cm column and 2-lm-beadpacked 50-cm column).
Mass spectra were acquired on a Thermo Scientific Orbitrap Elite instrument (Thermo Scientific) in a data-dependent manner using a standard top-20 method. Full-scan data were acquired at a resolving power of 60,000 with a maximum integration time of 250 ms. Scan range was fixed at 250-1250 m/z, and peptide fragmentation was performed in the higher collision dissociation (HCD) mode with an energy of 36 NSE. MS/MS spectra were acquired with 15,000 resolving power and a maximum integration time of 120 ms. Measurements were performed using m/z 445.120,025 as lock mass.
The raw data files were analyzed in the Proteome Discoverer software (Thermo Scientific), using the Sequest search engine and applying the Rattus Norvegicus Uniprot Fasta database (reviewed 28-1-2015) . MS/MS searches were performed using a 20 ppm parent ion mass tolerance and a 0.05 fragment mass tolerance. Trypsin was selected as the cleavage enzyme with up to two missed cleavage points. Cysteine methylthio modification was selected as a fixed modification, and oxidation of methionine was selected as a variable. Peptide identifications were considered valid at 1% false discovery rate (q-value <0.01) (percolator maximum Delta Cn was 0.05). The minimum length of acceptable identified peptides was set at six amino acids.
Samples were run three times to eliminate intrarun (intrasample) variation.
Full proteome and differently expressed proteins
Two complementary strategies were adopted to identify the proteomes at the different healing periods. For the 7-day samples, we considered part of the final proteome of the healthy/OVX animals only those proteins identified with MALDI-TOF/MS in at least four out of six animals. Through gel comparisons, we also spotted a list of proteins that were either up-or downregulated in the OVX animals compared to the healthy controls (or vice versa).
For the 14-and 30-day samples, we combined MALDI-TOF/MS and LC-MS/MS data. All proteins identified with the higher resolution LC-MS/MS technique were considered as part of the full proteome of that specific group and healing period. By comparing the lists of the expressed proteins in the two groups, we obtained a database of proteins that were present in one group and not in the other at each healing period, and which were considered, respectively, as up-or downregulated (on/off approach). The 3-10 pI 2-DE gels were used only for intergroup comparisons, so to identify further differently expressed proteins between the two groups.
PDQuest analysis
Proteins that were found as up-/downregulated according to the 2-DE gels analysis were processed with PDQuest 8.0 software (Bio-Rad), by applying a well-established protocol (Anagnostopoulos et al. 2015) . The aforementioned proteins were spotted in the relative gels, aligned, and automatically matched, as per manufacturer's instructions. Each spot was then manually inspected to verify the correct matching and eventually the spot volumes were obtained, which allowed a quantification of protein expression. After excluding the values of the background, spots were normalized in relation to the total quantity of all the valid spots in the gel. For each protein, we calculated the optical density level (OD%) as the sum of the volume percentage of all spots, from either the control or the OVX animals, which contained the same protein.
Clustering of proteins and network analysis
Each identified protein was matched to the related gene via the Uniprot database (http:// www.uniprot.org). Using Gene Ontology, proteins were classified according to their subcellular location, biological process, and molecular function, as previously described (Anagnostopoulos et al. 2011 (Anagnostopoulos et al. , 2015 . Whenever more than one annotation per protein was retrieved, they were all taken into consideration for the final result. Bioinformatics was performed by entering protein accession numbers in STRING v.10 database. The Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment tool was applied to study the signaling pathways involved at the different healing periods. Separate networks for the up-and downregulated proteins were created.
Results
The total number of different proteins detected at the different healing periods from the combination of 2-DE gels and LC-MS/MS analyses is presented in Table 1 .
7-day healing period
At this healing period, MALDI-TOF/MS was the only technique adopted, as the amount of retrieved proteins was limited and a number of samples were used to standardize the protocol.
A total of 2409 spots were analyzed (an average of 200 spots/gel), and 1585 were identified by MALDI-TOF/MS (65.8% identification rate). After removing duplicates, a total of 59 and 53 proteins were found in the healthy control and OVX animals, (Table 1) . As previously explained, only those proteins spotted in at least four out of six samples were considered as part of the full proteome of that specific group. This approach resulted in the final identification of 29 and 27 proteins in the healthy and OVX groups, respectively (Appendices S1 and S2). The spot pattern of the 7-day gels was extremely reproducible in both groups (Figs 2 and 3) . A total of 22 differently expressed proteins (8 down-and 14 upregulated) were detected and subsequently quantified through PDQuest analysis ( Table 2 ).
14-day healing period
For the 14-day samples, MALDI-TOF/MS was implemented with LC-MS/MS.
In particular, all the proteins detected with LC-MS/MS were considered as part of the full proteome of the animals. By comparing the proteomes of the two groups, we identified a few on/off proteins that were considered as up-/downregulated in one group compared with the other.
Conversely, the 2-DE gels were compared to identify only further differently expressed proteins between the two groups with MALDI-TOF/MS.
In every LC-MS run, the amount of loaded peptides was set to 5 lg. Buffer A was 0.1% formic acid in water, and buffer B was 99% acetonitrile, 1% water. Total elution time was 360 min, at a constant 3 nl/min flow rate. The gradient was optimized for prime peptide elution, in accordance with the material under process.
LC-MS/MS identified 103 proteins and 20 proteins as part of the proteome of the healthy control and OVX groups, respectively (Appendices S3 and S4).
By combining LC-MS/MS and MALDI-TOF/MS (94.7% identification rate), a final list of 24 up-and 89 downregulated proteins in the OVX rats compared with the healthy controls was obtained (Appendices S7 and S8). The different expression of the proteins detected with the 3-10 pI gels was investigated with PDQuest software (Table 2) .
30-day healing period
Following the same approach adopted for the 14-day samples, at 30 days of healing LC-MS/ MS identified 31 and 75 proteins in the healthy control and OVX rats, respectively, which were considered part of the full proteome of the animals (Appendices S5 and S6). By combining LC-MS/MS and MALDI-TOF/ MS (74.3% identification rate), a final list of 65 up-and 13 downregulated proteins in the OVX rats compared with the healthy controls was obtained (Appendices S9 and S10). The different expression of the proteins detected with the 3-10 pI gels was investigated with PDQuest software (Table 2) .
Clustering of proteins and pathway analysis
At 7 days of healing, the proteomes of both groups were very similar, with a predominance of proteins with a regulatory or transport activity, mainly involved in the inflammatory/immune response and hemostasis (Fig. 4) . Although most of the proteins were shared by both OVX and healthy control animals, this was not the case for gelsolin (GSN), guanine deaminase (GDA), and fetuin-B (FETUB), which were part only of the healthy controls' proteome. Most of the overexpressed proteins in the OVX group were involved in acute-phase response (APOA1, APOA4, HPT, FIBA, KNT1, and KNT2), platelet aggregation/activation, and coagulation cascade (FGG, FGA, COL1A1, KNT1, and KNT2; Fig. 5b ). Conversely, a few of the downexpressed proteins were involved in the dissolution of fibrin clot (PLMN, A1AT, ENOA; Fig. 5a ).
Unlike the 7-day healing period, the proteomes at 14 and 30 days were characteristically different between the two groups. At 14 days, in the healthy controls we found a predominance of secreted (32%) and cytoplasmatic (24%) proteins with enzymatic (29%) functions, while in the OVX rats most of the proteins were cytoplasmatic (22%) or nuclear (18%) proteins with transport (32%) or regulatory (26%) functions. In both groups, the Ras-related protein (Rap) 1, forkhead box O (FOXO), hypoxia-inducible factor (HIF)-1, and oxytocin signaling pathways were expressed. STRING 10 produced a network of predicted interactions between the over-and downregulated proteins in the OVX group compared with the control group that is shown in Fig. 6 . Among the overexpressed proteins in the OVX group, we identified the signal transducer and activator of transcription 3 (STAT3), which belongs also to the adipocytokine and chemokine signaling pathways (Fig. 6b) . On the contrary, proteins belonging to the peroxisome proliferator-activated receptors a (PPAR a) (e.g., APOC3, APOA1, APOA2), phosphatidylinositol-3 kinases/Akt (PI3K/AKT) (e.g., FN1, COL1A1, COL1A2), mitogen-activated protein kinases (MAPK) (e.g., FLNA), p53 (e.g., THBS1), and transforming growth factor-beta (TGF-beta) (via thrombospondin-1) signaling pathways were downregulated, as well as proteins involved in the classic and alternative complement cascade (C2, C3, CFH, C9; Fig. 6a ). At 30 days, the healthy controls expressed mainly nuclear (34%) proteins involved in the immune/inflammatory response (27%), while the OVX rats mainly expressed secreted (27%) proteins involved in the inflammatory response (11%) and coagulation/hemostasis (9%). Proteins involved in focal adhesion, extracellular matrix (ECM)-receptor interaction, cytoskeleton regulation and energy transduction/ATP synthesis, as well as proteins of the MAPK, HIF-1, and PI3K-AKT signaling pathways were expressed by both groups. Network analysis showed a higher expression of additional proteins belonging to the PI3K-AKT and MAPK signaling pathways (e.g., GNG12, VTN, SPP1, HSPA8), proteins involved in focal adhesion (e.g., VTN, SPP1), regulation of actin cytoskeleton (e.g., GNG12, GSN), complement/coagulation cascade (e.g., C2, FGB, FGA, PLMN), inflammatory response (APOA1, APOA4, SERPINA3N), and stress response (e.g., GPX1, SOD1, HIST1H3C) in the osteoporotic-like animals compared with the healthy animals (Fig. 7b) . Conversely, a downexpression of proteins belonging to vascular endothelial growth factor (VEGF) and MAPK signaling pathways (e.g., HSPB1) was reported in the OVX group (Fig. 7a) .
Discussion
This study showed a tendency for an enhanced inflammatory and oxidative stress response during osseous regeneration in OVX compared with healthy control animals. Furthermore, it suggested a delay in clot breakdown and granulation tissue maturation, as well as a trend toward a delayed/reduced recruitment and differentiation of osteoblast precursors in osteoporoticlike conditions. Proteomic data showed that in both groups the osseous formation process was quite immature, even at 30 days of healing. In fact, at this healing stage, a significant amount of proteins was still involved in the inflammatory/immune response and only limited proteins known to play a role in the later stages of woven bone formation and maturation were retrieved, thus confirming histology findings (see Part 1). This result may relate to the presence of a xenogenic material, which may have reduced the available space for osseous formation and may have therefore delayed the bone healing process, as previously documented (Slotte & Lundgren 1999; Stavropoulos et al. 2001; Donos et al. 2004 Donos et al. , 2005a Araujo et al. 2008) .
At 7 days of healing, the proteomes of both groups mainly consisted in proteins involved in the acute phase, platelet activation, and immune response, thus mirroring the gene expression analysis of Ivanovski et al. (2011) and Donos et al. (2011b) in GBR-treated rat calvarial defects. This finding reflects what we know about the bone formation cascade, as straight after a fracture or a bone defect is created, a blood clot forms and inflammatory cells invade the area, releasing cytokines and stimulating the recruitment of further inflammatory cells. The cytokine cascade, together with the release of other important mediators, subsequently brings the osteogenic cells into the wound (Schmidt-Bleek et al. 2012) .
Interestingly, most of the identified proteins at 7 days were associated with more than one gel spot. This indicated possible post-translation modifications, which would probably deserve further investigations, as they can significantly change protein activity and interaction (Choudhary & Mann 2010) .
The comparison between the over-and downexpressed proteins at 7 and 14 days suggested a delay in clot dissolution and granulation tissue organization in osteoporotic-like compared with healthy animals. In fact, while in the healthy animals the fibrinolysis and the recruitment of mesenchymal cells were taking place already at 7 days, in the OVX animals we had to wait 14 days to find the same expression level of the proteins involved in these biological processes (e.g., ENOA, PLMN, VIM).
At 14 days, proteins belonging to JAK-STAT, chemokine, and adipocytokine pathways were upregulated in the OVX compared to the healthy control rats. In particular, we found an overexpression of STAT3, a transcription factor that can be activated by many cytokines and growth factors, such as IL-6, PDGF, EGF, and is mainly involved in the regulation of cell cycle, angiogenesis, and inflammation (Aggarwal et al. 2009) . It has been shown that the activation of STAT3 further induces the expression of IL-6, as well as the expression of the receptor activator of RANKL, a cytokine that plays a crucial role for osteoclastogenesis. In addition, the overexpression of proteins belonging to the chemokine pathway, which is important in directing the migration of leukocytes during inflammation (Proost et al. 1996) , and the adipocytokine pathway, which partakes in the regulation of the inflammatory/immune response (Tilg & Moschen 2006) , strengthens the hypothesis of an enhanced inflammatory status in the OVX group. Our results are therefore consistent with the welldocumented increased inflammatory status associated with osteoporosis (McLean 2009), which seem to be similar under GBR conditions. Conversely, we found a downregulation of key components of PPARa, PI3K/AKT, MAPK, p53, and TGF-beta signaling pathways (e.g., APOC3, APOA1, FN1, COL1A1, THBS1), as well as proteins partaking in cell adhesion and ECM-receptor interaction at 14 days in the OVX group. Table 2 . Normalized volume (vol%) of the differently expressed proteins in the OVX rats at 7, 14, and 30 days (PDQuest output). The number of gels where the different protein expression was found is also reported. The proteins highlighted in light blue were also confirmed with LC-MS/MS analysis Peroxisome proliferator-activated receptors (PPARs) are "nuclear hormone receptors that are activated by fatty acids and their derivatives" (KEGG database). Particularly, PPARa promotes lipid oxidation and, by inhibiting nuclear factor-kappa B activity, it stimulates apoptosis of monocyte-derived macrophages (Fruchart et al. 1999) . The phosphatidylinositol-3 kinases/AKT (PI3K/ AKT) pathway and the mitogen-activated protein kinases (MAPKs) play a fundamental role in regulating cellular proliferation, . Besides the proteins that were actually retrieved, the network shows also the first five predicted functional partners with >0.99 score. The names of the proteins are listed in Table 2 growth, and survival of different cells, including osteoblasts, chondrocytes, and mesenchymal cell precursors (Jaiswal et al. 2000; Gallea et al. 2001; Xiao et al. 2002; Fujita et al. 2004; Rodriguez et al. 2004 Osterix transcription factors (Liu & Li 2010) . Finally, transforming growth factor-beta (TGF-beta) cooperates with Wnt in regulating the differentiation of mesenchymal cells into osteoblasts (Attisano & Labbe 2004) . A downregulation of the aforementioned pathways during bone regeneration may therefore be responsible of a reduced proliferation and differentiation of osteogenic precursor cells in osteoporotic-like conditions, as well as of an enhanced inflammatory response. At 14 days, a significant downregulation of proteins involved in both the classic and alternative pathway of the complement cascade (C2, C3, CFH, C9) was also identified in osteoporoticlike rats. This result is noteworthy if we consider that, besides a role in the elimination of damaged cells and innate immunity, the complement regulates cytokine/chemokine network and was demonstrated to be crucial in the healing of bone fractures (Ehrnthaller et al. 2013; Huber-Lang et al. 2013) .
As the osseous wound healing progresses, an increased energy supply is required, and this is why an increased number of proteins involved in energy transduction and ATP synthesis was detected in both groups at 14 and 30 days of healing. At the same time, an increased number of proteins involved in cell adhesion, proliferation, and differentiation in comparison with the 7-day healing period was detected, thus confirming gene data in a similar rat model (Ivanovski et al. 2011) . At 30 days, a higher number of proteins involved in regulatory activities and in signal transduction (e.g., transcription factors, chaperons) was also identified.
A few pathways involved in the differentiation of osteoblast precursors (such as PI3K/ AKT) and in the control of cell adhesion, migration, and differentiation were downregulated in the OVX group at 14 days (and therefore upregulated in the healthy controls), while an opposite trend was found at 30 days. As for the comparison between the 7-and 14-day proteins, we may interpret this finding as a delay in the activation of the aforecited pathways.
Remarkably, at 30 days proteins belonging to VEGF signaling pathway (e.g., HSPB1) were downexpressed in the OVX group. VEGF, a part from being a major angiogenetic factor, is highly expressed in osteoblast precursor cells. Recent evidence acknowledged an essential role of VEGF in promoting the differentiation of mesenchymal precursors toward the osteoblastic lineage instead of the adipogenic lineage (Liu et al. 2012 ).
Interestingly, apolipoprotein E and apolipoprotein A-IV were significantly overexpressed in the OVX rats at all healing periods and this tendency was quantified with PDQest analysis (up to 4.4. times for APOE and up to 10.25 times for APOA4). Apolipoproteins are involved in regulating lipoprotein metabolism and the transport of lipids between different cells and tissues (Mahley et al. 1984) . In recent years, APOE emerged as a potential regulator of bone metabolism. Mice studies documented the expression of APOE by osteoblasts and showed higher skeletal bone mass in APOE À/ À-animals, due to a higher bone formation rate (Bachner et al. 1999; Schilling et al. 2005) . Several speculations have been made regarding the molecular mechanisms behind the APOE-mediated regulation of bone metabolism. One possible explanation involves the APOE-mediated vitamin K intake into osteoblasts; otherwise, it is plausible that the APOE-mediated delivery of inhibitory lipidic molecules could negatively affect bone formation (Niemeier et al. 2012 ). Conversely, APOA4 was never attributed any bonerelated function. Our study is the first one to identify a significant upregulation of this protein in OVX animals, especially during later stages of bone healing (by 10.25 times at 30 days of healing), and we therefore believe this molecule would deserve further investigations.
Finally, a tendency toward an overexpression of proteins involved in stress response (e.g., SOD1, GPX1, PRDX2) was detected in the OVX animals at all healing periods. An increased/imbalanced oxidant status has been associated with bone loss, owing to the negative effect of free radicals on osteoblasts and osteoclasts (Wauquier et al. 2009 ). Our data are in line with clinical studies that found an increased oxidative stress in osteoporotic patients (Yousefzadeh et al. 2006; Cervellati et al. 2014) .
While this study has certainly the merit of having investigated for the first time protein expression at the different stages of bone regeneration in healthy and osteoporotic-like conditions, it presents with some limitations. In particular, although LC-MS/MS data are considered accurate (as they take into account the amino acid sequence of proteins) and MALDI-TOF/MS data were confirmed by pooling together results of several gels, the limited concentration of proteins retrieved did not allow to use an additional technique, such as Western blot, to further confirm our findings. This study should therefore be seen as an initial exploratory study that confirmed the usefulness of proteomic analysis in understanding the molecular mechanisms behind a complex biological process such as bone regeneration. We provided for the first time an insight on the normal succession of proteins released in the osseous wound and on the pathways involved at the different healing stages. By comparing the proteomes of healthy and OVX rats, we were also able to spot differences either in the timing of activation/inhibition of some signaling pathways or in the expression of proteins. This study opens the way to the possibility of understanding and, maybe in the future, manipulating these mechanisms, to promote superior and more predictable clinical results in osteoporotic patients. If confirmed by future studies, our findings may have a significant impact on the management of osteoporotic patients, which may for example benefit from longer healing periods after a bone regenerative procedure, or from adjunctive medical treatment to reduce the inflammatory/oxidative stress response and promote the recruitment and differentiation of osteoprogenitor cells.
While this project aimed to provide only a qualitative overlook of protein expression during bone regeneration, future studies should focus also on quantitative aspects, and sample size calculation will have to be performed accordingly.
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